<!DOCTYPE html>

<html lang="en">
<head>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-EPQ9202NVY"></script>
<script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      
      //- gtag('config', 'UA-71059016-1');
      gtag('config', 'G-EPQ9202NVY');
      
    </script>
<title>PDB-101: Molecule of the Month: Human Papillomavirus and Vaccines</title>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<meta content="PDB101: Molecule of the Month: Human Papillomavirus and Vaccines" property="og:title"/>
<meta content="The capsid protein of papillomavirus is used in vaccines that prevent cervical cancer." property="og:description"/>
<meta content="https://cdn.rcsb.org/pdb101/motm/221/222-Human_Papillomavirus_and_Vaccines-3j6r-6bt3.jpg" property="og:image"/>
<meta content="http://pdb101.rcsb.org/motm/221" property="og:url"/>
<meta content="RCSB: PDB-101" property="og:site_name"/>
<meta content="summary" name="twitter:card"/>
<meta content="PDB101: Molecule of the Month: Human Papillomavirus and Vaccines" name="twitter:title"/>
<meta content="The capsid protein of papillomavirus is used in vaccines that prevent cervical cancer." name="twitter:description"/>
<meta content="https://cdn.rcsb.org/pdb101/motm/221/222-Human_Papillomavirus_and_Vaccines-3j6r-6bt3.jpg" name="twitter:image"/>
<meta content="The capsid protein of papillomavirus is used in vaccines that prevent cervical cancer." name="description"/>
<meta content="cancer,capsid,papillomavirus,warts,vaccine,virus-like particle,VLP,antibody,oncogene,HPV,3j6r,6bt3,4xr8,5w1o,5y9f" name="keywords"/>
<!-- associate with our Google Analytics-->
<meta content="A8M31jAX8SUgQYzbnF5r-wgykna2i5Hp4J9fziVD9Sg" name="google-site-verification"/>
<link href="https://cdn.rcsb.org/pdb101/common/jquery-ui-1.11.4/jquery-ui.min.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/bootstrap/latest/css/bootstrap.min.css" rel="stylesheet"/>
<link href="https://pdb101.rcsb.org/ekko-lightbox/ekko-lightbox.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/fontawesome/fontawesome-free-6.7.2/css/all.min.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/timeline3/css/timeline.css" rel="stylesheet"/>
<link href="https://pdb101.rcsb.org/css/style.css?v=20171201" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/jira-feedback/css/jira-fdbck.css" rel="stylesheet"/><!--[if lt IE 9]>
    <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
    <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script><![endif]-->
<script src="https://cdn.rcsb.org/javascript/jquery/jquery-2.2.4.min.js"></script>
<script src="https://cdn.rcsb.org/pdb101/common/jquery-ui-1.11.4/jquery-ui.min.js"></script>
<script src="https://cdn.rcsb.org/javascript/bootstrap/latest/js/bootstrap.min.js"></script>
<script src="https://pdb101.rcsb.org/ekko-lightbox/ekko-lightbox.min.js"></script>
<script src="https://pdb101.rcsb.org/js/common.js"></script>
<script src="https://cdn.rcsb.org/jira-feedback/js/jira-fdbck.min.js"></script>
</head>
<body>
<div class="container" id="main_content">
<style>
          #jmolTabs {
              margin: 20px 0;
          }
          
          .motm-hr {
              color: #ccc;
              background-color: #ccc;
              height: 1px;
              border: none;
          }
          
          .jmolText {
              font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
              font-size: 14px;
          }
          
          /* over-write bootstrap values */
          .nav-tabs {
              background: linear-gradient(to bottom, #fff, #ddd);
          }
          
          .tab-content {
              border-left: 1px solid #ddd;
              border-right: 1px solid #ddd;
              border-bottom: 1px solid #ddd;
              border-bottom-right-radius: 4px;
              border-bottom-left-radius: 4px;
              padding: 15px;
          }
          .nav-tabs > li.active > a, .nav-tabs > li.active > a:hover, .nav-tabs > li.active > a:focus {
              background-color: #fff;
              color: #333;
          }
          
          .tab-pane {
              padding-bottom: 10px;
          }
          
          #tabs-1 img {
              cursor: pointer;
          }
          
          .fa-cloud-download { margin-left:10px; }
          /* customize div.img-with-caption in style.css */
          div.img-with-caption {
              max-width: 50%;
              margin-top: 10px;
          }
          div.float-right { float: right; margin-left: 20px; }
          div.float-left { float: left; margin-right: 20px; }
          
          .link-motm {
              background-color: #d9ebd294;
              padding: 10px;
              border-radius: 4px;
              border: 1px solid #bcedbd;
              overflow-wrap: break-word;
          }
          div.jmol-image { margin-bottom: 5px; }
          
        </style>
<script>
          // jmol script
          var jmolLoaded = false
          function loadIframe() {
              if (jmolLoaded == false) {
                  var src = '/motm/jmol/?id=' + 221
                  console.log('src=' + src)
                  $("#iframe").attr('src', src)
                  jmolLoaded = true
              }
          }
          function clickJmolTab() {
              $('#jmol-tab').trigger('click')
          }
          
          // jmol script for legacy motms with multiple jmols
          var jmols = [];
          function loadIframeById(jmolId) {
              var jmol = jmols[jmolId - 1]
              if (jmol.loaded == false) {
                  var src = '/motm/jmol/?id=' + 221 + '&jmolId=' + jmolId
                  $("#iframe_" + jmolId).attr('src', src)
                  jmol.loaded = true
              }
          }
          function clickJmolTab(i) {
              var j = i + 1
              $('#jmol-tab-' + j).trigger('click')
          }
          
        </script>

<div data-elastic-include="">
<h1>Molecule of the Month: Human Papillomavirus and Vaccines</h1>
<p><i>The capsid protein of papillomavirus is used in vaccines that prevent cervical cancer.</i></p>
<div>
<div class="img-with-caption float-right">
<div class="img-with-caption-table"><img alt="Structures of papillomavirus capsid from cryoelectron microscopy. Capsomeres in orange are surrounded by five other capsomeres, and the ones in red are surrounded by six neighbors. The structure at the bottom is covered with many virus-specific antibodies (blue, only the Fab portion of the antibody is included in the structure)." class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/221/222-Human_Papillomavirus_and_Vaccines-3j6r-6bt3.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>Structures of papillomavirus capsid from cryoelectron microscopy. Capsomeres in orange are surrounded by five other capsomeres, and the ones in red are surrounded by six neighbors. The structure at the bottom is covered with many virus-specific antibodies (blue, only the Fab portion of the antibody is included in the structure).</i></div>
</div>
</div>
</div>
<div>Papillomaviruses are annoying pests that occasionally turn into deadly dangers. They attack cells in our skin and mucous membranes. When they infect cells, they ramp up the normal growth functions, often forming warts. Usually our defenses are able to get the infection under control, but in some exceptional cases, the virus persists and the unwanted growth can turn into cancer. Alarmingly, infection by a few particularly-virulent types of papillomavirus is the leading cause of cervical cancer. Fortunately, by studying these viruses, scientists have discovered highly effective ways to fight them.</div>
<h4>A Tiny Danger</h4>
<div>Papillomavirus is a small virus, with a simple capsid surrounding a circular DNA genome. The capsid (PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3j6r" target="_blank">3j6r</a>) includes 360 copies of the major capsid chain, called L1. A second capsid chain, called L2, is found on the inside and may help with packaging the genome. The capsid structure, however, is not a typical <a href="https://pdb101.rcsb.org/motm/200">quasisymmetrical virus</a>. Instead, like <a href="https://pdb101.rcsb.org/motm/47">simian virus 40</a>, the L1 chains form 72 pentameric “capsomeres”, which then interact with one another through long flexible tails.</div>
<h4>VLPs and Vaccines</h4>
<div>As soon as researchers discovered that these viruses cause cancer, they started looking for vaccines to fight them. Currently, the most effective approach is to create a “virus-like particle” that is composed of the L1 protein, but doesn’t include the DNA. The immune system builds defenses against these VLPs, but they are not infectious, so they are safe to use as a vaccine. PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=6bt3" target="_blank">6bt3</a> shows how <a href="https://pdb101.rcsb.org/motm/21">antibodies</a> coat the surface of the virus, making it unable to infect cells.</div>
<h4>Perfecting Vaccines</h4>
<div>Many types of papillomaviruses infect humans, and researchers have perfected several prophylactic vaccines to fight the most dangerous ones. The bivalent vaccine targets the two major types involved in cervical cancer, types 16 and 18. The quadrivalent vaccine adds types 6 and 11, which cause most genital warts, and the nonavalent vaccine adds an additional 5 oncogenic strains, giving it an even wider spectrum of activity. The capsids shown here are type 16 papillomavirus, the most common cause of cervical cancer worldwide.</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<div>
<div class="img-with-caption float-left">
<div class="img-with-caption-table"><img alt="Structure of papillomavirus E6 protein with portions of p53 tumor suppressor and ubiquitin ligase E6AP." class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/221/222-Human_Papillomavirus_and_Vaccines-4xr8.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>Structure of papillomavirus E6 protein with portions of p53 tumor suppressor and ubiquitin ligase E6AP.</i></div>
</div>
</div>
</div>
<h4>Causing Cancer</h4>
<div>The papillomavirus genome encodes two small proteins, called E6 and E7, that act as cancer-causing oncogenes in particularly dangerous strains. Together they stimulate unnatural growth of cells and block their natural defenses. They act on many different cellular signaling proteins that control diverse processes such as proliferation and apoptosis. PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=4xr8" target="_blank">4xr8</a> captures E6 doing one of its terrible tasks. In the structure, it is forming a linkage between <a href="https://pdb101.rcsb.org/motm/31">p53 tumor suppressor</a> and <a href="https://pdb101.rcsb.org/motm/60">ubiquitin ligase</a>, which will ultimately lead to the destruction of p53 by <a href="https://pdb101.rcsb.org/motm/166">proteasomes</a>. In this way, the virus stops the cell from using apoptosis to terminate the infection.</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<h4>Exploring the Structure</h4>
<div class="jmolText" id="jmolTabs">
<ul class="nav nav-tabs">
<li class="active"><a data-toggle="tab" href="#tabs-1">Image</a></li>
<li><a data-toggle="tab" href="#tabs-2" id="jmol-tab" onclick="loadIframe();">JSmol</a></li>
</ul>
<div class="tab-content">
<div class="tab-pane active" id="tabs-1">
<h5>Human Papillomavirus</h5>
<div class="img-with-caption float-left" style="margin-top:0;"><img class="img-responsive" onclick="clickJmolTab();" src="https://cdn.rcsb.org/pdb101/motm/221/222-Human_Papillomavirus_and_Vaccines-JSmol.jpg"/></div>
<p>Papillomavirus binds to heparin molecules on the surface of the cells that it infects. Crystallographic structures of isolated L1 capsomeres have revealed that the heparin chains (on the left in green) are recognized by lysine-lined grooves on the surface of the virus (PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=5w1o" target="_blank">5w1o</a>). Similar L1 capsomere structures with antibodies (on the right in blue) show that they can block this recognition, thus blocking attachment to the cell (PDB entry <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=5y9f" target="_blank">5y9f</a>). To compare these two structures, click on the image for an interactive JSmol.</p>
<div class="clearfix"></div>
</div>
<div class="tab-pane" id="tabs-2">
<iframe frameborder="0" id="iframe" marginheight="0" marginwidth="0" scrolling="yes" width="100%"></iframe>
</div>
</div>
</div>
<div class="row">
<div class="col-xs-12 col-sm-12 col-md-6">
<h4>Topics for Further Discussion</h4>
<ol>
<li>You can search for “papillomavirus E7” to explore structures of the E7 oncogenic protein. Can you figure out why papillomavirus proteins E1-E8 are named with the letter "E" and the two capsid proteins are named with the letter "L"?</li>
<li>Try searching for “capsid” in PDB-101 or the main RCSB site to see many ways that viruses build capsids.</li>
<li>Click on this link to download and build a <a href="https://pdb101.rcsb.org/learn/paper-models/human-papillomavirus-hpv">paper model of papillomavirus.</a></li>
</ol>
<div data-elastic-exclude="">
<div class="col-xs-12 link-motm">
<h4>Related PDB-101 Resources</h4>
<ul>
<li>Browse <a href="https://pdb101.rcsb.org/browse/cancer">Cancer</a></li>
<li>Browse <a href="https://pdb101.rcsb.org/browse/viruses">Viruses</a></li>
<li>Browse <a href="https://pdb101.rcsb.org/browse/vaccines">Vaccines</a></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-12 col-md-6" style="border-left:1px dashed #ddd;">
<h4>References</h4>
<ol>
<li><a href="http://www.who.int/wer/2017/wer9219/en">World Health Organization position paper on human papillomavirus vaccines. Weekly Epidemiological Record, 12 May 2017, vol. 92, 19 (pp. 241-268). </a></li>
<li>6bt3: J Guan, SM Bywaters, SA Brendle, RE Ashley, AM Makhov, JF Conway, ND Christensen &amp; S Hafenstein (2017) High-resolution structure analysis of antibody V5 and U4 conformational epitopes on human papillomavirus 16. Viruses 9, 374.</li>
<li>5y9f: Z Li, D Wang, Y Gu, S Song, M He, J Shi, X Liu, S Wei, J Li, H Yu, Q Zheng, X Yan, TS Baker, J Zhang, JS McLellan, S Li &amp; N Xia (2017) Crystal structures of two immune complexes identify determinants for viral infectivity and type-specific neutralization of human papillomavirus. MBio 8, e00787-17</li>
<li>4xr8: D Martinez-Zapien, FX Ruiz, J Poirson, A Mitschler, J Ramirez, A Forster, A Cousido-Siah, M Masson, SV Pol, A Podjarny, G Trave &amp; K Zanier (2016) Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature 529, 541-545.</li>
<li>3j6r: G Cardone, AL Moyer, N Cheng, CD Thompson, I Dvoretzky, DR Lowy, JT Schiller, AC Steven, CB Buck &amp; BL Trus. (2014) Maturation of the human papillomavirus 16 capsid. MBio 5, e01104-14.</li>
<li>5w1o: J Dasgupta, M Bienkowska-Haba, ME Ortega, HD Patel, S Bodevin, D Spillmann, B Bishop, M Sapp &amp; XS Chen (2011) Structural basis of oligosaccharide receptor recognition by human papillomavirus. Journal of Biological Chemistry 286, 2617-2624.</li>
<li>I Suarez &amp; G Trave (2008) Structural insights in multifunctional papillomavirus oncoproteins. Viruses 10, 37.</li>
<li>DR Lowy &amp; JT Schiller (2006) Prophylactic human papillomavirus vaccines. Journal of Clinical Investigation 116, 1167-1173.</li>
</ol>
</div>
</div>
<hr class="motm-hr"/>
<p>May 2018, David Goodsell</p> <a href="http://doi.org/10.2210/rcsb_pdb/mom_2018_5">http://doi.org/10.2210/rcsb_pdb/mom_2018_5</a>
</div>
<div class="row hidden-print" style="margin-top:20px;">
<div class="col-xs-12">
<div class="panel panel-info">
<div class="panel-heading">About Molecule of the Month</div>
<div class="panel-body"><small>
                   
                  The RCSB PDB Molecule of the Month by David S. Goodsell (The Scripps Research Institute and the RCSB PDB) presents short accounts on selected molecules from the Protein Data Bank. Each installment includes an introduction to the structure and function of the molecule, a discussion of the relevance of the molecule to human health and welfare, and suggestions for how visitors might view these structures and access further details.<a href="https://pdb101.rcsb.org/motm/motm-about">More</a></small>
</div>
</div>
</div>
</div>
<script>
          $('#iframe').load(function () {
              $(this).height($(this).contents().find('body').height() + 30);
          });
        </script>
</div>
</body>
</html>
